{"entity":{"type":"insider","cik":"0001521548","url":"/insider/0001521548","json_url":"/insider/0001521548.json","name":"Halstead Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":81,"n_filings":41,"first":"2011-10-03","last":"2024-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Halstead Michael","source":"filing","n_filings":41,"first_seen":"2011-10-03","last_seen":"2024-11-14"}],"transactions":[{"id":2143270,"accession":"0000950170-24-127275","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-24-127275","line_url":"/filing/0000950170-24-127275","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18714.0,"shares_display":"18,714","price_per_share":88.384131131773,"price_display":"88.38","price_state":"stated","total_value":1654020.63,"total_display":"1,654,020.63","total_whole":"1,654,021","shares_owned_after":5343.0,"shares_owned_after_display":"5,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-13","filed_date":"2024-11-14","scope":"insider","n_lines":2},{"id":2143259,"accession":"0000950170-24-127275","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-127275","line_url":"/filing/0000950170-24-127275","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22869.0,"shares_display":"22,869","price_per_share":89.11974288337925,"price_display":"89.12","price_state":"stated","total_value":2038079.4,"total_display":"2,038,079.40","total_whole":"2,038,079","shares_owned_after":7764.0,"shares_owned_after_display":"7,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-14","scope":"insider","n_lines":3},{"id":2115942,"accession":"0000950170-24-029581","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-029581","line_url":"/filing/0000950170-24-029581","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7345.0,"shares_display":"7,345","price_per_share":65.96832402995234,"price_display":"65.97","price_state":"stated","total_value":484537.34,"total_display":"484,537.34","total_whole":"484,537","shares_owned_after":1238.0,"shares_owned_after_display":"1,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-11","scope":"insider","n_lines":2},{"id":2115932,"accession":"0000950170-24-029581","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-029581","line_url":"/filing/0000950170-24-029581","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13132.0,"shares_display":"13,132","price_per_share":66.15122448979592,"price_display":"66.15","price_state":"stated","total_value":868697.88,"total_display":"868,697.88","total_whole":"868,698","shares_owned_after":220.0,"shares_owned_after_display":"220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider","n_lines":2},{"id":2415335,"accession":"0000950170-24-021575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-021575","line_url":"/filing/0000950170-24-021575","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7907.0,"shares_display":"7,907","price_per_share":69.53130896673834,"price_display":"69.53","price_state":"stated","total_value":549784.06,"total_display":"549,784.06","total_whole":"549,784","shares_owned_after":392.0,"shares_owned_after_display":"392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider","n_lines":3},{"id":2203327,"accession":"0000950170-24-011400","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-011400","line_url":"/filing/0000950170-24-011400","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11860.0,"shares_display":"11,860","price_per_share":66.41816188870152,"price_display":"66.42","price_state":"stated","total_value":787719.4,"total_display":"787,719.40","total_whole":"787,719","shares_owned_after":714.0,"shares_owned_after_display":"714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-05","scope":"insider","n_lines":2},{"id":2766768,"accession":"0000950170-24-004320","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-004320","line_url":"/filing/0000950170-24-004320","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":66.8339708,"price_display":"66.83","price_state":"stated","total_value":3341698.54,"total_display":"3,341,698.54","total_whole":"3,341,699","shares_owned_after":1486.0,"shares_owned_after_display":"1,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider","n_lines":3},{"id":8547677,"accession":"0001209191-23-055207","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-055207","line_url":"/filing/0001209191-23-055207","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":53.8956576,"price_display":"53.90","price_state":"stated","total_value":2694782.88,"total_display":"2,694,782.88","total_whole":"2,694,783","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-14","scope":"insider","n_lines":2},{"id":7968318,"accession":"0001209191-23-018285","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-018285","line_url":"/filing/0001209191-23-018285","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7344.0,"shares_display":"7,344","price_per_share":44.93555555555555,"price_display":"44.94","price_state":"stated","total_value":330006.72,"total_display":"330,006.72","total_whole":"330,007","shares_owned_after":476.0,"shares_owned_after_display":"476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-13","scope":"insider","n_lines":2},{"id":7968313,"accession":"0001209191-23-018285","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-018285","line_url":"/filing/0001209191-23-018285","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16708.0,"shares_display":"16,708","price_per_share":43.09825233421115,"price_display":"43.10","price_state":"stated","total_value":720085.6,"total_display":"720,085.60","total_whole":"720,086","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-13","scope":"insider","n_lines":2},{"id":8722880,"accession":"0001209191-23-013437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013437","line_url":"/filing/0001209191-23-013437#line-2","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7906.0,"shares_display":"7,906","price_per_share":47.03,"price_display":"47.03","price_state":"stated","total_value":371819.18,"total_display":"371,819.18","total_whole":"371,819","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":8436634,"accession":"0001209191-23-011997","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-011997","line_url":"/filing/0001209191-23-011997","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11139.0,"shares_display":"11,139","price_per_share":46.835321842176135,"price_display":"46.84","price_state":"stated","total_value":521698.65,"total_display":"521,698.65","total_whole":"521,699","shares_owned_after":1843.0,"shares_owned_after_display":"1,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider","n_lines":4},{"id":6548997,"accession":"0001209191-22-059507","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-059507","line_url":"/filing/0001209191-22-059507","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":53.7302768,"price_display":"53.73","price_state":"stated","total_value":2686513.84,"total_display":"2,686,513.84","total_whole":"2,686,514","shares_owned_after":22796.0,"shares_owned_after_display":"22,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider","n_lines":2},{"id":6812638,"accession":"0001209191-22-013356","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-013356","line_url":"/filing/0001209191-22-013356","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7906.0,"shares_display":"7,906","price_per_share":51.9774095623577,"price_display":"51.98","price_state":"stated","total_value":410933.4,"total_display":"410,933.40","total_whole":"410,933","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-25","scope":"insider","n_lines":2},{"id":6623199,"accession":"0001209191-22-012392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-012392","line_url":"/filing/0001209191-22-012392","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11139.0,"shares_display":"11,139","price_per_share":55.39998294281354,"price_display":"55.40","price_state":"stated","total_value":617100.41,"total_display":"617,100.41","total_whole":"617,100","shares_owned_after":4550.0,"shares_owned_after_display":"4,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider","n_lines":2},{"id":6242391,"accession":"0001209191-22-002989","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-002989","line_url":"/filing/0001209191-22-002989","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19639.0,"shares_display":"19,639","price_per_share":40.7746886297673,"price_display":"40.77","price_state":"stated","total_value":800774.11,"total_display":"800,774.11","total_whole":"800,774","shares_owned_after":4380.0,"shares_owned_after_display":"4,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider","n_lines":3},{"id":4493895,"accession":"0001209191-21-071176","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-071176","line_url":"/filing/0001209191-21-071176","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":176863.0,"shares_display":"176,863","price_per_share":47.563808484533226,"price_display":"47.56","price_state":"stated","total_value":8412277.86,"total_display":"8,412,277.86","total_whole":"8,412,278","shares_owned_after":49468.0,"shares_owned_after_display":"49,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-21","filed_date":"2021-12-23","scope":"insider","n_lines":5},{"id":4177242,"accession":"0001209191-21-012951","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-012951","line_url":"/filing/0001209191-21-012951","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11139.0,"shares_display":"11,139","price_per_share":39.24346171110513,"price_display":"39.24","price_state":"stated","total_value":437132.92,"total_display":"437,132.92","total_whole":"437,133","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-22","scope":"insider","n_lines":2},{"id":5034320,"accession":"0001209191-21-003316","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-003316","line_url":"/filing/0001209191-21-003316","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19638.0,"shares_display":"19,638","price_per_share":32.02859456156431,"price_display":"32.03","price_state":"stated","total_value":628977.54,"total_display":"628,977.54","total_whole":"628,978","shares_owned_after":1936.0,"shares_owned_after_display":"1,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider","n_lines":2},{"id":4256673,"accession":"0001209191-21-001528","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-001528","line_url":"/filing/0001209191-21-001528","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16160.0,"shares_display":"16,160","price_per_share":31.3016150990099,"price_display":"31.30","price_state":"stated","total_value":505834.1,"total_display":"505,834.10","total_whole":"505,834","shares_owned_after":3174.0,"shares_owned_after_display":"3,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider","n_lines":2},{"id":2739493,"accession":"0001209191-20-059544","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-059544","line_url":"/filing/0001209191-20-059544","is_derivative":false,"issuer_cik":"0001521548","issuer_name":"Intra-Cellular Therapies, Inc.","issuer_ticker":"ITCI","issuer_name_source":null,"issuer_url":"/issuer/0001521548","owner_cik":"0001521548","owner_name":"Halstead Michael","owner_display_name":"Halstead Michael","owner_url":"/insider/0001521548","role":"Officer (EVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79425.0,"shares_display":"79,425","price_per_share":27.616573497009757,"price_display":"27.62","price_state":"stated","total_value":2193446.35,"total_display":"2,193,446.35","total_whole":"2,193,446","shares_owned_after":3761.0,"shares_owned_after_display":"3,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2020-11-17|2739488","ledger_fault":false,"count":{"value":81,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":79,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":81},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001567514","name":"Intra-Cellular Therapies, Inc.","url":"/issuer/0001567514","role":"Officer (President)","n_filings":27,"first_seen":"2014-11-06","last_seen":"2024-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001323854","name":"Warner Chilcott plc","url":"/issuer/0001323854","role":"Officer (Senior V.P., Corp. Development)","n_filings":14,"first_seen":"2011-10-03","last_seen":"2013-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001521548","retrieved_at":"2026-08-24T15:13:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}